Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.

Saved in:
Bibliographic Details
Title: Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.
Authors: Tompkins AG; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Gray ZN; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Dadey RE; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Zenkin S; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Batavani N; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Newman S; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Amouzegar A; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Ak M; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Ak N; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Pak TY; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Peddagangireddy V; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mamindla P; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Amjadzadeh M; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Behr S; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Goodman A; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Ploucha DL; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Zarour HM; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Najjar YG; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Davar D; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Tatsuoka C; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Colen RR; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Luke JJ; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA baor@upmc.edu lukejj@upmc.edu.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Bao R; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA baor@upmc.edu lukejj@upmc.edu.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 12; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 12.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-009568